Sign In

Login

Password

Forgot Password ? Sign Up

Biontech (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Biontech" in German language version.

Last modified:

Ref.Un. Ref.Website
Global rank German rank
2913web.archive.org
1st place
1st place
2620doi.org
2nd place
3rd place
2610redirecter.toolforge.org
29th place
2nd place
2519nih.gov
5th place
7th place
1212zdb-katalog.de
107th place
5th place
117biontech.de
low place
low place
1010handelsblatt.com
1,281st place
75th place
98faz.net
282nd place
12th place
55spiegel.de
87th place
6th place
53biontech.com
low place
low place
52pharmazeutische-zeitung.de
low place
730th place
33bmbf.de
low place
3,310th place
33aerzteblatt.de
3,794th place
234th place
33welt.de
255th place
11th place
33pharma-food.de
low place
low place
33deutsche-apotheker-zeitung.de
low place
1,049th place
32sueddeutsche.de
267th place
10th place
32deraktionaer.de
low place
3,996th place
31apotheke-adhoc.de
low place
2,037th place
22nzz.ch
710th place
40th place
22nature.com
207th place
227th place
22goingpublic.de
low place
low place
22nasdaq.com
3,313th place
3,917th place
22european-biotechnology.com
low place
low place
22aerztezeitung.de
low place
870th place
22tagesschau.de
772nd place
42nd place
224investors.de
low place
low place
22tagesspiegel.de
503rd place
26th place
22chemanager-online.com
low place
4,936th place
22zeit.de
301st place
14th place
22businessinsider.de
8,368th place
674th place
22allgemeine-zeitung.de
low place
905th place
22cleanroomtechnology.com
low place
low place
21eurams.de
low place
low place
22europa.eu
62nd place
21st place
11youtube.com
13th place
8th place
11manager-magazin.de
3,151st place
211th place
11schweizeraktien.net
low place
low place
11wiwo.de
4,050th place
279th place
11pharma-zeitung.de
low place
low place
11adlershof.de
low place
low place
11bio-m.org
low place
low place
11volksstimme.de
6,234th place
409th place
11eib.org
7,617th place
7,066th place
11bundesregierung.de
6,004th place
555th place
11ft.com
193rd place
481st place
11nau.ch
low place
899th place
11topionetworks.com
low place
low place
11taz.de
603rd place
31st place
11stuttgarter-zeitung.de
2,688th place
180th place
11businesswire.com
828th place
1,341st place
11mig-fonds.de
low place
low place
11uni-marburg.de
7,233rd place
902nd place
11novartis.de
low place
low place
11juve.de
low place
1,975th place
11dw.com
205th place
128th place
11rnd.de
3,569th place
231st place
11t3n.de
low place
1,215th place
11zdf.de
1,615th place
93rd place
11fiercebiotech.com
low place
low place
11unimedizin-mainz.de
low place
low place
11gatesfoundation.org
low place
low place
11capital.de
low place
1,627th place
11kooperation-international.de
low place
9,721st place
11finanzwelt.de
low place
low place
11onvista.de
low place
3,595th place
11rws-verlag.de
low place
low place
11lto.de
6,456th place
418th place
11pressebox.de
low place
1,452nd place
11vogel.de
9,101st place
653rd place
11clusterplattform.de
low place
low place
11dzif.de
low place
low place
11t-online.de
1,448th place
83rd place
11merkurist.de
low place
4,932nd place
11bmj.com
1,341st place
1,738th place
11cbinsights.com
low place
low place
11justia.com
673rd place
2,141st place
11patent-anmelden.net
low place
low place
11epo.org
low place
4,845th place
11wyborcza.pl
531st place
1,370th place
11n-tv.de
1,358th place
74th place

4investors.de (Global: low place; German: low place)

adlershof.de (Global: low place; German: low place)

aerzteblatt.de (Global: 3,794th place; German: 234th place)

aerztezeitung.de (Global: low place; German: 870th place)

allgemeine-zeitung.de (Global: low place; German: 905th place)

apotheke-adhoc.de (Global: low place; German: 2,037th place)

bio-m.org (Global: low place; German: low place)

biontech.com (Global: low place; German: low place)

biontech.de (Global: low place; German: low place)

investors.biontech.de

biontech.de

bmbf.de (Global: low place; German: 3,310th place)

bmj.com (Global: 1,341st place; German: 1,738th place)

  • Madlen Davies: Covid-19: WHO efforts to bring vaccine manufacturing to Africa are undermined by the drug industry, documents show. In: BMJ. Band 376, 9. Februar 2022, ISSN 1756-1833, S. o304, doi:10.1136/bmj.o304, PMID 35140068 (bmj.com [abgerufen am 23. März 2022]).

bundesregierung.de (Global: 6,004th place; German: 555th place)

businessinsider.de (Global: 8,368th place; German: 674th place)

businesswire.com (Global: 828th place; German: 1,341st place)

capital.de (Global: low place; German: 1,627th place)

cbinsights.com (Global: low place; German: low place)

chemanager-online.com (Global: low place; German: 4,936th place)

cleanroomtechnology.com (Global: low place; German: low place)

clusterplattform.de (Global: low place; German: low place)

deraktionaer.de (Global: low place; German: 3,996th place)

deutsche-apotheker-zeitung.de (Global: low place; German: 1,049th place)

doi.org (Global: 2nd place; German: 3rd place)

  • Rojas, L.A., Sethna, Z., Soares, K.C. et al.: Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. In: Nature. Band 618, Nr. 7963, Juni 2023, ISSN 1476-4687, S. 144–150, doi:10.1038/s41586-023-06063-y, PMID 37165196, PMC 10171177 (freier Volltext) – (nature.com [abgerufen am 17. Januar 2026]).
  • Lena M. Kranz, Mustafa Diken, Heinrich Haas, Sebastian Kreiter, Carmen Loquai: Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. In: Nature. Band 534, Nr. 7607, 16. Juni 2016, ISSN 1476-4687, S. 396–401, doi:10.1038/nature18300, PMID 27281205.
  • U. Sahin, K. Karikó, Ö. Türeci: mRNA-based therapeutics – developing a new class of drugs. In: Nat Rev Drug Discov. Band 13, Nr. 10, 2014, S. 759–780, doi:10.1038/nrd4278, PMID 25233993.
  • S. Kreiter, A. Selmi, M. Diken, M. Koslowski, C. M. Britten, C. Huber, O. Tureci, U. Sahin: Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity. In: Cancer Res. Band 70, Nr. 22, 2010, S. 9031–9040, doi:10.1158/0008-5472.CAN-10-0699, PMID 21045153.
  • U. Sahin, E. Derhovanessian, M. Miller, B. P. Kloke, P. Simon, M. Löwer, V. Bukur, A. D. Tadmor, U. Luxemburger, B. Schrörs, T. Omokoko, M. Vormehr, C. Albrecht, A. Paruzynski, A. N. Kuhn, J. Buck, S. Heesch, K. H. Schreeb, F. Müller, I. Ortseifer, I. Vogler, E. Godehardt, S. Attig, R. Rae, A. Breitkreuz, C. Tolliver, M. Suchan, G. Martic, A. Hohberger, P. Sorn, J. Diekmann, J. Ciesla, O. Waksmann, A. K. Brück, M. Witt, M. Zillgen, A. Rothermel, B. Kasemann, D. Langer, S. Bolte, M. Diken, S. Kreiter, R. Nemecek, C. Gebhardt, S. Grabbe, C. Höller, J. Utikal, C. Huber, C. Loquai, Ö. Türeci: Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. In: Nature. Band 547, Nr. 7662, 2017, S. 222–226, doi:10.1038/nature23003, PMID 28678784.
  • U. Sahin, Ö. Türeci: Personalized vaccines for cancer immunotherapy. In: Science. Band 359, Nr. 6382, 2018, S. 1355–1360, doi:10.1126/science.aar7112, PMID 29567706.
  • C. R. Stadler, H. Bähr-Mahmud, L. Celik, B. Hebich, A. S. Roth, R. P. Roth, K. Karikó, Ö. Türeci, U. Sahin: Elimination of large tumors in mice by mRNA-encoded bispecific antibodies. In: Nat Med. Band 23, Nr. 7, 2017, S. 815–817, doi:10.1038/nm.4356, PMID 28604701.
  • Christiane R Stadler, Hayat Bähr-Mahmud, Laura M Plum, Kathrin Schmoldt, Anne C Kölsch, Özlem Türeci, Ugur Sahin: Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6. In: Oncoimmunology. Band 5, Nr. 3, 2015, S. e1091555, doi:10.1080/2162402X.2015.1091555, PMID 27141353.
  • P. Simon, T. A. Omokoko, A. Breitkreuz, L. Hebich, S. Kreiter, S. Attig, A. Konur, C. M. Britten, C. Paret, K. Dhaene u. a.: Functional TCR retrieval from single antigen-specific human T cells reveals multiple novel epitopes. In: Cancer Immunol Res. Band 2, Nr. 12, 2014, S. 1230–1244, doi:10.1158/2326-6066.CIR-14-0108, PMID 25245536.
  • T. Omokoko, P. Simon, O. Tureci, U. Sahin: Retrieval of functional TCRs from single antigen-specific T cells: Toward individualized TCR-engineered therapies. In: Oncoimmunology. Band 4, Nr. 7, 2015, S. e1005523, doi:10.1080/2162402X.2015.1005523, PMID 26140230.
  • C. P. Sommerhoff, O. Avrutina, H. U. Schmoldt, D. Gabrijelcic-Geiger, U. Diederichsen, H. Kolmar: Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase beta. In: J Mol Biol. Band 395, Nr. 1, 2010, S. 167–175, doi:10.1016/j.jmb.2009.10.028, PMID 19852971.
  • O. Avrutina, H. U. Schmoldt, D. Gabrijelcic-Geiger, A. Wentzel, H. Frauendorf, C. P. Sommerhoff, U. Diederichsen, H. Kolmar: Head-to-tail cyclized cystine-knot peptides by a combined recombinant and chemical route of synthesis. In: Chembiochem. Band 9, Nr. 1, 2008, S. 33–37, doi:10.1002/cbic.200700452, PMID 18058774.
  • S. Krause, H. U. Schmoldt, A. Wentzel, M. Ballmaier, K. Friedrich, H. Kolmar: Grafting of thrombopoietin-mimetic peptides into cystine knot miniproteins yields high-affinity thrombopoietin antagonists and agonists. In: FEBS J. Band 274, Nr. 1, 2007, S. 86–95, doi:10.1111/j.1742-4658.2006.05567.x, PMID 17147697.
  • T. Klamp, J. Schumacher, G. Huber, C. Kuhne, U. Meissner, A. Selmi, T. Hiller, S. Kreiter, J. Markl, O. Tureci u. a.: Highly specific auto-antibodies against claudin-18 isoform 2 induced by a chimeric HBcAg virus-like particle vaccine kill tumor cells and inhibit the growth of lung metastases. In: Cancer Res. Band 71, Nr. 2, 2011, S. 516–527, doi:10.1158/0008-5472.CAN-10-2292, PMID 21224362.
  • M. Vormehr, M. Diken, S. Boegel, S. Kreiter, Ö. Türeci, U. Sahin: Mutanome directed cancer immunotherapy. In: Curr Opin Immunol. Band 39, 2016, S. 14–22, doi:10.1016/j.coi.2015.12.001, PMID 26716729.
  • M. R. Stratton, P. J. Campbell, P. A. Futreal: The cancer genome. In: Nature. Band 458, Nr. 7239, 2009, S. 719–724, doi:10.1038/nature07943, PMID 19360079.
  • M. R. Stratton: Exploring the genomes of cancer cells: progress and promise. In: Science. Band 331, Nr. 6024, 2011, S. 1553–1558, doi:10.1126/science.1204040, PMID 21436442.
  • S. Kreiter, J. C. Castle, Ö. Türeci, U. Sahin: Targeting the tumor mutanome for personalized vaccination therapy. In: Oncoimmunology. Band 1, Nr. 5, 2012, S. 768–769, doi:10.4161/onci.19727, PMID 22934277.
  • Madlen Davies: Covid-19: WHO efforts to bring vaccine manufacturing to Africa are undermined by the drug industry, documents show. In: BMJ. Band 376, 9. Februar 2022, ISSN 1756-1833, S. o304, doi:10.1136/bmj.o304, PMID 35140068 (bmj.com [abgerufen am 23. März 2022]).
  • Cecilia Martin, Drew Lowery: mRNA vaccines: intellectual property landscape. In: Nature Reviews Drug Discovery. Band 19, Nr. 9, 27. Juli 2020, S. 578–578, doi:10.1038/d41573-020-00119-8 (nature.com [abgerufen am 12. November 2020]).

dw.com (Global: 205th place; German: 128th place)

dzif.de (Global: low place; German: low place)

  • Kooperationen. Deutsches Zentrum für Infektionsforschung, abgerufen am 11. November 2020.

eib.org (Global: 7,617th place; German: 7,066th place)

epo.org (Global: low place; German: 4,845th place)

eurams.de (Global: low place; German: low place)

europa.eu (Global: 62nd place; German: 21st place)

ec.europa.eu

ema.europa.eu

european-biotechnology.com (Global: low place; German: low place)

faz.net (Global: 282nd place; German: 12th place)

fiercebiotech.com (Global: low place; German: low place)

finanzwelt.de (Global: low place; German: low place)

ft.com (Global: 193rd place; German: 481st place)

markets.ft.com

gatesfoundation.org (Global: low place; German: low place)

sif.gatesfoundation.org

  • Biontech. The Gates Foundation, abgerufen am 11. November 2020 (englisch).

goingpublic.de (Global: low place; German: low place)

handelsblatt.com (Global: 1,281st place; German: 75th place)

justia.com (Global: 673rd place; German: 2,141st place)

patents.justia.com

juve.de (Global: low place; German: 1,975th place)

kooperation-international.de (Global: low place; German: 9,721st place)

lto.de (Global: 6,456th place; German: 418th place)

manager-magazin.de (Global: 3,151st place; German: 211th place)

merkurist.de (Global: low place; German: 4,932nd place)

mig-fonds.de (Global: low place; German: low place)

n-tv.de (Global: 1,358th place; German: 74th place)

nasdaq.com (Global: 3,313th place; German: 3,917th place)

nature.com (Global: 207th place; German: 227th place)

nau.ch (Global: low place; German: 899th place)

nih.gov (Global: 5th place; German: 7th place)

ncbi.nlm.nih.gov

  • Rojas, L.A., Sethna, Z., Soares, K.C. et al.: Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. In: Nature. Band 618, Nr. 7963, Juni 2023, ISSN 1476-4687, S. 144–150, doi:10.1038/s41586-023-06063-y, PMID 37165196, PMC 10171177 (freier Volltext) – (nature.com [abgerufen am 17. Januar 2026]).
  • Lena M. Kranz, Mustafa Diken, Heinrich Haas, Sebastian Kreiter, Carmen Loquai: Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. In: Nature. Band 534, Nr. 7607, 16. Juni 2016, ISSN 1476-4687, S. 396–401, doi:10.1038/nature18300, PMID 27281205.
  • U. Sahin, K. Karikó, Ö. Türeci: mRNA-based therapeutics – developing a new class of drugs. In: Nat Rev Drug Discov. Band 13, Nr. 10, 2014, S. 759–780, doi:10.1038/nrd4278, PMID 25233993.
  • S. Kreiter, A. Selmi, M. Diken, M. Koslowski, C. M. Britten, C. Huber, O. Tureci, U. Sahin: Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity. In: Cancer Res. Band 70, Nr. 22, 2010, S. 9031–9040, doi:10.1158/0008-5472.CAN-10-0699, PMID 21045153.
  • U. Sahin, E. Derhovanessian, M. Miller, B. P. Kloke, P. Simon, M. Löwer, V. Bukur, A. D. Tadmor, U. Luxemburger, B. Schrörs, T. Omokoko, M. Vormehr, C. Albrecht, A. Paruzynski, A. N. Kuhn, J. Buck, S. Heesch, K. H. Schreeb, F. Müller, I. Ortseifer, I. Vogler, E. Godehardt, S. Attig, R. Rae, A. Breitkreuz, C. Tolliver, M. Suchan, G. Martic, A. Hohberger, P. Sorn, J. Diekmann, J. Ciesla, O. Waksmann, A. K. Brück, M. Witt, M. Zillgen, A. Rothermel, B. Kasemann, D. Langer, S. Bolte, M. Diken, S. Kreiter, R. Nemecek, C. Gebhardt, S. Grabbe, C. Höller, J. Utikal, C. Huber, C. Loquai, Ö. Türeci: Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. In: Nature. Band 547, Nr. 7662, 2017, S. 222–226, doi:10.1038/nature23003, PMID 28678784.
  • U. Sahin, Ö. Türeci: Personalized vaccines for cancer immunotherapy. In: Science. Band 359, Nr. 6382, 2018, S. 1355–1360, doi:10.1126/science.aar7112, PMID 29567706.
  • C. R. Stadler, H. Bähr-Mahmud, L. Celik, B. Hebich, A. S. Roth, R. P. Roth, K. Karikó, Ö. Türeci, U. Sahin: Elimination of large tumors in mice by mRNA-encoded bispecific antibodies. In: Nat Med. Band 23, Nr. 7, 2017, S. 815–817, doi:10.1038/nm.4356, PMID 28604701.
  • Christiane R Stadler, Hayat Bähr-Mahmud, Laura M Plum, Kathrin Schmoldt, Anne C Kölsch, Özlem Türeci, Ugur Sahin: Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6. In: Oncoimmunology. Band 5, Nr. 3, 2015, S. e1091555, doi:10.1080/2162402X.2015.1091555, PMID 27141353.
  • P. Simon, T. A. Omokoko, A. Breitkreuz, L. Hebich, S. Kreiter, S. Attig, A. Konur, C. M. Britten, C. Paret, K. Dhaene u. a.: Functional TCR retrieval from single antigen-specific human T cells reveals multiple novel epitopes. In: Cancer Immunol Res. Band 2, Nr. 12, 2014, S. 1230–1244, doi:10.1158/2326-6066.CIR-14-0108, PMID 25245536.
  • T. Omokoko, P. Simon, O. Tureci, U. Sahin: Retrieval of functional TCRs from single antigen-specific T cells: Toward individualized TCR-engineered therapies. In: Oncoimmunology. Band 4, Nr. 7, 2015, S. e1005523, doi:10.1080/2162402X.2015.1005523, PMID 26140230.
  • C. P. Sommerhoff, O. Avrutina, H. U. Schmoldt, D. Gabrijelcic-Geiger, U. Diederichsen, H. Kolmar: Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase beta. In: J Mol Biol. Band 395, Nr. 1, 2010, S. 167–175, doi:10.1016/j.jmb.2009.10.028, PMID 19852971.
  • O. Avrutina, H. U. Schmoldt, D. Gabrijelcic-Geiger, A. Wentzel, H. Frauendorf, C. P. Sommerhoff, U. Diederichsen, H. Kolmar: Head-to-tail cyclized cystine-knot peptides by a combined recombinant and chemical route of synthesis. In: Chembiochem. Band 9, Nr. 1, 2008, S. 33–37, doi:10.1002/cbic.200700452, PMID 18058774.
  • S. Krause, H. U. Schmoldt, A. Wentzel, M. Ballmaier, K. Friedrich, H. Kolmar: Grafting of thrombopoietin-mimetic peptides into cystine knot miniproteins yields high-affinity thrombopoietin antagonists and agonists. In: FEBS J. Band 274, Nr. 1, 2007, S. 86–95, doi:10.1111/j.1742-4658.2006.05567.x, PMID 17147697.
  • T. Klamp, J. Schumacher, G. Huber, C. Kuhne, U. Meissner, A. Selmi, T. Hiller, S. Kreiter, J. Markl, O. Tureci u. a.: Highly specific auto-antibodies against claudin-18 isoform 2 induced by a chimeric HBcAg virus-like particle vaccine kill tumor cells and inhibit the growth of lung metastases. In: Cancer Res. Band 71, Nr. 2, 2011, S. 516–527, doi:10.1158/0008-5472.CAN-10-2292, PMID 21224362.
  • M. Vormehr, M. Diken, S. Boegel, S. Kreiter, Ö. Türeci, U. Sahin: Mutanome directed cancer immunotherapy. In: Curr Opin Immunol. Band 39, 2016, S. 14–22, doi:10.1016/j.coi.2015.12.001, PMID 26716729.
  • M. R. Stratton, P. J. Campbell, P. A. Futreal: The cancer genome. In: Nature. Band 458, Nr. 7239, 2009, S. 719–724, doi:10.1038/nature07943, PMID 19360079.
  • M. R. Stratton: Exploring the genomes of cancer cells: progress and promise. In: Science. Band 331, Nr. 6024, 2011, S. 1553–1558, doi:10.1126/science.1204040, PMID 21436442.
  • S. Kreiter, J. C. Castle, Ö. Türeci, U. Sahin: Targeting the tumor mutanome for personalized vaccination therapy. In: Oncoimmunology. Band 1, Nr. 5, 2012, S. 768–769, doi:10.4161/onci.19727, PMID 22934277.
  • Madlen Davies: Covid-19: WHO efforts to bring vaccine manufacturing to Africa are undermined by the drug industry, documents show. In: BMJ. Band 376, 9. Februar 2022, ISSN 1756-1833, S. o304, doi:10.1136/bmj.o304, PMID 35140068 (bmj.com [abgerufen am 23. März 2022]).

novartis.de (Global: low place; German: low place)

nzz.ch (Global: 710th place; German: 40th place)

onvista.de (Global: low place; German: 3,595th place)

patent-anmelden.net (Global: low place; German: low place)

pharma-food.de (Global: low place; German: low place)

pharma-zeitung.de (Global: low place; German: low place)

pharmazeutische-zeitung.de (Global: low place; German: 730th place)

pressebox.de (Global: low place; German: 1,452nd place)

redirecter.toolforge.org (Global: 29th place; German: 2nd place)

rnd.de (Global: 3,569th place; German: 231st place)

rws-verlag.de (Global: low place; German: low place)

schweizeraktien.net (Global: low place; German: low place)

spiegel.de (Global: 87th place; German: 6th place)

stuttgarter-zeitung.de (Global: 2,688th place; German: 180th place)

sueddeutsche.de (Global: 267th place; German: 10th place)

t-online.de (Global: 1,448th place; German: 83rd place)

t3n.de (Global: low place; German: 1,215th place)

tagesschau.de (Global: 772nd place; German: 42nd place)

tagesspiegel.de (Global: 503rd place; German: 26th place)

taz.de (Global: 603rd place; German: 31st place)

  • Finn Mayer-Kuckuk: Porträt über die Biontech-Chefs: Das Forscherpaar. In: Die Tageszeitung. 10. November 2020, ISSN 0931-9085 (taz.de [abgerufen am 11. November 2020]).

topionetworks.com (Global: low place; German: low place)

uni-marburg.de (Global: 7,233rd place; German: 902nd place)

unimedizin-mainz.de (Global: low place; German: low place)

vogel.de (Global: 9,101st place; German: 653rd place)

process.vogel.de

volksstimme.de (Global: 6,234th place; German: 409th place)

  • Johannes Vetter: Mit doppelter Kraft gegen das Coronavirus. In: Volksstimme. (Magdeburg). 11. November 2020 (volksstimme.de [abgerufen am 11. November 2020]).

web.archive.org (Global: 1st place; German: 1st place)

welt.de (Global: 255th place; German: 11th place)

wiwo.de (Global: 4,050th place; German: 279th place)

wyborcza.pl (Global: 531st place; German: 1,370th place)

youtube.com (Global: 13th place; German: 8th place)

zdb-katalog.de (Global: 107th place; German: 5th place)

  • Rojas, L.A., Sethna, Z., Soares, K.C. et al.: Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. In: Nature. Band 618, Nr. 7963, Juni 2023, ISSN 1476-4687, S. 144–150, doi:10.1038/s41586-023-06063-y, PMID 37165196, PMC 10171177 (freier Volltext) – (nature.com [abgerufen am 17. Januar 2026]).
  • Corona-Impfstoff: Biontech fährt Impfstoffproduktion in Marburg hoch. In: Der Spiegel. 10. Februar 2021, ISSN 2195-1349 (spiegel.de [abgerufen am 8. Juli 2024]).
  • Lena M. Kranz, Mustafa Diken, Heinrich Haas, Sebastian Kreiter, Carmen Loquai: Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. In: Nature. Band 534, Nr. 7607, 16. Juni 2016, ISSN 1476-4687, S. 396–401, doi:10.1038/nature18300, PMID 27281205.
  • Gefährliche Corona-Varianten: Biontech und Instadeep entwickeln Frühwarnsystem. In: Tagesspiegel. 11. Januar 2022, ISSN 1865-2263 (tagesspiegel.de [abgerufen am 9. Juli 2024]).
  • Biotechnologie: Curevac-Übernahme durch Biontech wird im Januar vollendet. In: Die Zeit. 18. Dezember 2025, ISSN 0044-2070 (zeit.de [abgerufen am 19. Januar 2026]).
  • Finn Mayer-Kuckuk: Porträt über die Biontech-Chefs: Das Forscherpaar. In: Die Tageszeitung. 10. November 2020, ISSN 0931-9085 (taz.de [abgerufen am 11. November 2020]).
  • Sebastian Balzter: Impfen gegen Corona: „Das wird noch einige Jahre dauern, fürchte ich“. In: Frankfurter Allgemeine Zeitung. ISSN 0174-4909 (faz.net [abgerufen am 11. November 2020]).
  • Thorsten Winter: Krebs und Infektionen: Neuartige Impfstoffe als Ziel. In: Frankfurter Allgemeine Zeitung. ISSN 0174-4909 (faz.net [abgerufen am 11. November 2020]).
  • Markus Schug: Millionen-Dollar-Förderung: Geld von Bill Gates für Mainzer Forscher. In: Frankfurter Allgemeine Zeitung. ISSN 0174-4909 (faz.net [abgerufen am 11. November 2020]).
  • Friederike Böge: Taipeh ist verärgert: Hat BioNTech Taiwan zur Aufgabe der Selbstbezeichnung als Land gedrängt? In: Frankfurter Allgemeine Zeitung. ISSN 0174-4909 (faz.net [abgerufen am 16. Juni 2021]).
  • Wucherforderung für Impfstoff? Biontech-Gründer Şahin weist das zurück. In: Der Spiegel. 20. Februar 2021, ISSN 2195-1349 (spiegel.de [abgerufen am 9. Juli 2024]).
  • Madlen Davies: Covid-19: WHO efforts to bring vaccine manufacturing to Africa are undermined by the drug industry, documents show. In: BMJ. Band 376, 9. Februar 2022, ISSN 1756-1833, S. o304, doi:10.1136/bmj.o304, PMID 35140068 (bmj.com [abgerufen am 23. März 2022]).

zdf.de (Global: 1,615th place; German: 93rd place)

zeit.de (Global: 301st place; German: 14th place)

  • Biotechnologie: Curevac-Übernahme durch Biontech wird im Januar vollendet. In: Die Zeit. 18. Dezember 2025, ISSN 0044-2070 (zeit.de [abgerufen am 19. Januar 2026]).
  • Ingo Malcher: Biontech: Im Team gegen Corona. In: Die Zeit. 3. Juni 2020 (zeit.de [abgerufen am 27. November 2020]).